
Scott Long
Examiner (ID: 10754, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15145003
[patent_doc_number] => 20190350979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => UNDIFFERENTIATED STEM CELL REMOVAL AGENT AND METHOD FOR REMOVING UNDIFFERENTIATED STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/468951
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468951
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/468951 | UNDIFFERENTIATED STEM CELL REMOVAL AGENT AND METHOD FOR REMOVING UNDIFFERENTIATED STEM CELLS | Dec 13, 2017 | Abandoned |
Array
(
[id] => 13325971
[patent_doc_number] => 20180214523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => INJECTION SOLUTION FOR RNA
[patent_app_type] => utility
[patent_app_number] => 15/835403
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15835403
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/835403 | INJECTION SOLUTION FOR RNA | Dec 6, 2017 | Abandoned |
Array
(
[id] => 12764446
[patent_doc_number] => 20180146650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => MMTV-SV40-Spy1A and Spy1A-pTRE Transgenic Mouse Models
[patent_app_type] => utility
[patent_app_number] => 15/823036
[patent_app_country] => US
[patent_app_date] => 2017-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15823036
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/823036 | MMTV-SV40-Spy1A and Spy1A-pTRE transgenic mouse models | Nov 26, 2017 | Issued |
Array
(
[id] => 12886036
[patent_doc_number] => 20180187187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => SELF-ASSEMBLING MOLECULAR NANOSYSTEM FOR TARGETED DNA AND GENE DELIVERY
[patent_app_type] => utility
[patent_app_number] => 15/821559
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821559 | SELF-ASSEMBLING MOLECULAR NANOSYSTEM FOR TARGETED DNA AND GENE DELIVERY | Nov 21, 2017 | Abandoned |
Array
(
[id] => 18012153
[patent_doc_number] => 11504427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy
[patent_app_type] => utility
[patent_app_number] => 16/463316
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 12990
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 396
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463316
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463316 | Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy | Nov 21, 2017 | Issued |
Array
(
[id] => 12880723
[patent_doc_number] => 20180185416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING HIV
[patent_app_type] => utility
[patent_app_number] => 15/816454
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15816454
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/816454 | METHODS AND COMPOSITIONS FOR TREATING HIV | Nov 16, 2017 | Abandoned |
Array
(
[id] => 12657139
[patent_doc_number] => 20180110879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => SMOOTH MUSCLE SPECIFIC INHIBITION FOR ANTI-RESTENOTIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/806007
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806007
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/806007 | Smooth muscle specific inhibition for anti-restenotic therapy | Nov 6, 2017 | Issued |
Array
(
[id] => 12724282
[patent_doc_number] => 20180133261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => TREATMENT OF PAIN USING PLACENTAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 15/801318
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15801318
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/801318 | TREATMENT OF PAIN USING PLACENTAL STEM CELLS | Oct 31, 2017 | Abandoned |
Array
(
[id] => 16861770
[patent_doc_number] => 11020492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
[patent_app_type] => utility
[patent_app_number] => 16/346237
[patent_app_country] => US
[patent_app_date] => 2017-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21971
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346237
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346237 | Gene correction of SCID-related genes in hematopoietic stem and progenitor cells | Oct 30, 2017 | Issued |
Array
(
[id] => 12601524
[patent_doc_number] => 20180092338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/793901
[patent_app_country] => US
[patent_app_date] => 2017-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15793901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/793901 | Genetically modified cells, tissues, and organs for treating disease | Oct 24, 2017 | Issued |
Array
(
[id] => 16058723
[patent_doc_number] => 10688285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Spinal subpial gene delivery system
[patent_app_type] => utility
[patent_app_number] => 15/790477
[patent_app_country] => US
[patent_app_date] => 2017-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 80
[patent_no_of_words] => 17201
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15790477
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/790477 | Spinal subpial gene delivery system | Oct 22, 2017 | Issued |
Array
(
[id] => 17602911
[patent_doc_number] => 11331380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Cereblon-based heterodimerizable chimeric antigen receptors
[patent_app_type] => utility
[patent_app_number] => 16/343375
[patent_app_country] => US
[patent_app_date] => 2017-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17968
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343375
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343375 | Cereblon-based heterodimerizable chimeric antigen receptors | Oct 18, 2017 | Issued |
Array
(
[id] => 13124881
[patent_doc_number] => 10080353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Porcine reproductive and respiratory syndrome virus resistant animals
[patent_app_type] => utility
[patent_app_number] => 15/783417
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13729
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15783417
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/783417 | Porcine reproductive and respiratory syndrome virus resistant animals | Oct 12, 2017 | Issued |
Array
(
[id] => 15496267
[patent_doc_number] => 20200048322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => T CELLS EXPRESSING MEMBRANE-ANCHORED IL-12 FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/339691
[patent_app_country] => US
[patent_app_date] => 2017-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -99
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339691
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339691 | T cells expressing membrane-anchored IL-12 for the treatment of cancer | Oct 5, 2017 | Issued |
Array
(
[id] => 16321497
[patent_doc_number] => 10781453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus
[patent_app_type] => utility
[patent_app_number] => 15/721517
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 37286
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721517
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721517 | Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus | Sep 28, 2017 | Issued |
Array
(
[id] => 12580719
[patent_doc_number] => 20180085402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => COMPOSITIONS AND METHODS RELATED TO MULTIMODAL THERAPEUTIC CELL SYSTEMS FOR CANCER INDICATIONS
[patent_app_type] => utility
[patent_app_number] => 15/716141
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15716141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/716141 | Compositions and methods related to engineered erythoid cells comprising 4-1BBL | Sep 25, 2017 | Issued |
Array
(
[id] => 12126509
[patent_doc_number] => 20180010095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'T Cells with Increased Immunosuppression Resistance'
[patent_app_type] => utility
[patent_app_number] => 15/713464
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13533
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15713464
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/713464 | T cells with increased immunosuppression resistance | Sep 21, 2017 | Issued |
Array
(
[id] => 14578493
[patent_doc_number] => 20190216855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/330858
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330858 | Method of targeting oncolytic viruses to tumors | Sep 18, 2017 | Issued |
Array
(
[id] => 17814307
[patent_doc_number] => 11419894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Modified natural killer cells for the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 16/332981
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18278
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332981
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332981 | Modified natural killer cells for the treatment of cancer | Sep 14, 2017 | Issued |
Array
(
[id] => 14045773
[patent_doc_number] => 20190078993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => Method of Characterization of Exosomes
[patent_app_type] => utility
[patent_app_number] => 15/703216
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703216 | Method of characterization of exosomes | Sep 12, 2017 | Issued |